Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
H.L. Hall & Sons is a diversified South African conglomerate, established in 1890, with a significant historical and ongoing presence in the healthcare and life sciences sectors. The company is widely recognized for its Halls Pharma division, which for decades served as a leading marketer and distributor of specialized pharmaceutical products in Southern Africa, particularly in ophthalmology, dermatology, and respiratory health. Although the group divested its primary pharmaceutical distribution business to Ascendis Health in 2014, it continues to engage with the life sciences through strategic investments and its agricultural biotechnology operations. Headquartered in Mbombela, the group leverages its extensive regional infrastructure to support the commercialization of healthcare solutions and high-quality fresh produce. The company remains one of the oldest and most respected family-owned businesses in the region, integrating a heritage of agriculture with a commitment to health and wellness.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on H.L. Hall & Sons.